Crowdonomics
All companies
LOVE LIFESCIENCES logo

LOVE LIFESCIENCES

Operating

Love Lifesciences LLC

Healthcare · Founded 2021

Revolutionizing the injection experience. Ensuring patients love life

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$399,000
Crowd $124K · Private $275K · 2 rounds since 2022

Financials

FY2020–FY2021 · from SEC filings · hover any figure for its source
$0
2020
$0
−$9K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed*
FY2021 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
-$9,426
Taxes paid
$0
$0
Balance sheet
Cash
$0
$1,806
Accounts receivable
$0
$12,000
Total assets
$0
$24,336
Short-term debt
$0
$0
Long-term debt
$0
$25,000
Total liabilities
$0
$25,000
Other
Headcount
—
3

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Raised $275KInvestors 2
Reg CF · SAFE · Sep 2022Closedvia WeFunder
Raised $124K / $124KInvestors 43

Team

2 people
Bradley HopperFounder
Co-Founder and CTO
Nick LoveFounder
Co-Founder and CEO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 4 annual reports (FY2022–FY2025)

Missing: 2022, 2023, 2024, 2025

43 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form DNov 23, 20220001940540-22-000002
    EDGAR
  • Form C/AOct 17, 20220001670254-22-001076
    EDGAR
  • Form CSep 12, 20220001670254-22-000942
    EDGAR
Source: ManualCIK 0001940540

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.